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Recentgeneticstudiesshowedevidenceforaroleofthesingle-nucleotidepolymorphismrs2522833withinthePCLOgeneinthe
etiology of major depression, and rs2522833 has been shown to modulate hypothalamic pituitary adrenal (HPA) axis activity
duringantidepressanttreatment. Monoaminergicmodulation oftheHPAsystemmaybeonepossiblepathomechanismbywhich
PCLO exerts its effect on depression. In the present study, we investigated the effect of rs2522833 on the cortisol awakening
response(CAR)inhealthyyoungadults.Atotalof66healthyvolunteersfromthecommunity(36menand30women)aged18–25
years without individual or family history of affective disorders and schizophrenia collected saliva cortisol samples at 0, 30, 45
and 60min after awakening on two consecutive working days. We identiﬁed a blunted CAR (AUCinc) in rs2522833 risk-allele
(C) carriers, possibly indicating exhausted regulatory mechanisms underlying the HPA system. We also identiﬁed higher
neuroticism scores in rs2522833 risk-allele carriers but no phenotypic correlation between the CAR (AUCinc) and neuroticism.
These ﬁndings suggest that the rs2522833 risk variant might increase vulnerability to depression both by physiological and
behavioral pathways, which appear, however, not to be substantially overlapped. Replication with larger samples is warranted.
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Introduction
A recent genome-wide association study
1 showed evidence
for a role of the single-nucleotide polymorphism rs2522833
within the piccolo (PCLO) gene in the etiology of major
depression, which was supported by a subsequent
meta-analysis
2 and joint reanalysis of correlated multiple
single-nucleotide polymorphisms.
3 Another region in PCLO
has been associated with bipolar disorder.
4 Furthermore,
rs2522833 modulated hypothalamic pituitary adrenal (HPA)
axis activity during antidepressant treatment.
5 In this report,
we show that rs2522833 impacts HPA axis regulation in
healthy young adults.
The protein product of the PCLO gene is relevant for
monoaminergic neurotransmission in the brain, making it a
plausible candidate gene for affective disorders. Although the
original genome-wide association study
1 and the subsequent
meta-analysis
2 replicated positive ﬁndings only in population-
based samples, rs2522833 inﬂuence on HPA system
response to antidepressants has been observed in
depressed patients, referred as inpatients.
5 Here, C-allele
carriers showed larger HPA dysregulation than AA-carriers.
This study suggests monoaminergic modulation of the HPA
system as one possible pathomechanism by which PCLO
exerts its effect on depression.
In the present study, we sought to investigate the effect of
rs2522833 on HPA system activity in healthy young adults.
Investigating healthy samples allows to measure effects of
common gene variants on physiological and behavioral
phenotypes, which are not yet confounded with but possibly
increase vulnerability to depression. As a physiological
marker, we investigated the cortisol awakening response
(CAR), denoting the rise in cortisol levels during the ﬁrst hour
after awakening. The CAR reﬂects the sensitivity of the HPA
axis in response to a naturally occurring stressor (awakening)
and has gained growing attention because of its distinct
association with stress and psychopathology,
6 and its higher
genetic liability than daytime cortisol levels.
7 In depression,
both increased and blunted CARs have been identiﬁed,
7
possibly because of different subgroups and/or severity of
illness. A recent meta-analysis that also included community
studies concluded that the CAR is negatively correlated with
depression, especially its dynamic component.
7 A blunted
morning rise in cortisol levels has also been identiﬁed in
healthy subjects with cognitive vulnerability to depression.
8
Therefore, we expected particularly the dynamic aspect
of the CAR to be lower in C-allele carriers.
In parallel to physiological phenotypes, personality traits
may underlie the association between rs2522833 and vulner-
ability to depression. Particularly neuroticism has been shown
to have a clear genetic overlap with major depression and to
predict the subsequent onset of the disorder.
9 Furthermore,
as neuroticism reﬂects a tendency to cope poorly with stress,
9
HPA axis (dys)function may be involved in this association.
Therefore, we also aimed to investigate the association
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www.nature.com/tpbetween rs2522833 and neuroticism, as well as a possible
phenotypic relationship between the CAR and neuroticism.
Subjects and methods
We recruited 66 healthy volunteers aged 18–25 years
(36 men and 30 women) from the community without
individual or family history of affective disorders and schizo-
phrenia. On two consecutive working days, participants
collected four saliva cortisol samples per day during the ﬁrst
hour after awakening (at awakening, þ30min, þ45min and
þ60min).Participantswereinstructednottobrushtheirteeth
or eat, drink and smoke during sampling periods, and to
record exact sampling times and adherence to the protocol.
Saliva samples were analyzed using a time-resolved
ﬂuorescence immunoassay. Intra- and interassay variability
were o10%. Cortisol samples for each time point were
averaged across days. If subjects did not adhere to the
protocol for a probe, these values were excluded from
analyses. For the CAR, we calculated both the area under
thecurvewithrespecttoincrease(AUCinc)andwithrespect to
the ground (AUCg). The AUCinc denotes the dynamic
ﬂuctuation of the system from the awakening baseline,
whereas AUCg is an estimate of total cortisol secretion during
the ﬁrst hour.
10 Analyses of covariance involving genotype
(AA- versus C-allele carriers) as independent factor and CAR
components as dependent variables were controlled for
depressive symptom levels, sex, age and habitual smoking.
Depressive symptoms were measured with the Beck
Depression Inventory, second revision,
11 and neuroticism
was measured with the Neo-Five-Factor Inventory subscale
neuroticism.
12 The analysis of covariance involving neuroti-
cism as dependent variable was controlled for depressive
symptoms.
Rs2522833 was genotyped using a TaqMan 50 nuclease
assay. A duplication of 15% of the sample revealed
reproducibility of 100%. Allele frequencies (AA: 30.3%, AC:
56.1% and CC: 13.6%) were in Hardy–Weinberg equilibrium
(P40.05). Owing to small numbers of CC homozygotes, we
pooled subjects with AC and CC genotypes (risk-allele
carriers, n¼46).
Results and discussion
Compared with rs2522833 AA-carriers, C-allele carriers
showed signiﬁcantly lower CAR_AUCinc than AA-carriers
(282.0±319.1 versus 467.0±269.1, F(1,61)¼4.35,
P¼0.042, see Figure 1), but similar CAR_AUCg
(1074.3±305.2 versus 1115.7±368.2, F(1,61)¼0.07, not
signiﬁcant). Furthermore, C-carriers scored higher on neuro-
ticism than AA-carriers (18.6±6.7 versus 15.5±6.7,
F(1,63)¼4.17, P¼0.045). However, by adjusting for age,
sex and habitual smoking, neuroticism was not correlated
with CAR_AUCinc (rpartial¼ 0.116, not signiﬁcant), and its
inclusion as a further covariate in a respective analysis
of covariance model did not affect the signiﬁcant asso-
ciation between rs2522833 genotype and CAR_AUCinc
(F (1,60)¼4.40, P¼0.041).
Although these results clearly need replication in larger
samples, they point to a possible inﬂuence of rs2522833 on
both HPA activation and neuroticism. These associations
were not due to genotype group differences in subclinical
symptoms, which were controlled in the respective models.
Both dysregulation of the CAR and neuroticism have been
identiﬁed as vulnerability factors for depression.
6–10 As
hypothesized, rs2522833 was associated particularly with
the dynamic component of the CAR,
7 and the blunted CAR
increase in risk-allele carriers might indicate exhausted
regulatory mechanisms underlying the HPA system. Further-
more, we identiﬁed an association between rs2522833
genotype and neuroticism, but no phenotypic correlation
betweenCAR_AUCincand neuroticism.Therefore,our results
suggest that the rs2522833 risk variant might increase
vulnerability to depression both by physiological and
by behavioral pathways, which appear, however, not to be
substantially overlapped. Alternatively, unknown factors may
have masked the relationship between CAR_AUCinc and
neuroticism. Finally, it is not yet known whether rs2522833
itself or a variant in disequilibrium with it is causally linked to
physiological and behavioral phenotypes.
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Figure 1 The cortisol awakening response (CAR) for rs2522833 AA- and
C-allele carriers. (a) Course of cortisol during the ﬁrst hour after awakening. (b) The
CAR area under the curve with respect to increase (AUCinc). In both graphs, error
bars represent standard errors of the mean. *Po0.05.
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